Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Shares Outstanding (2023 - 2025)

Hinge Health (HNGE) has disclosed Shares Outstanding for 3 consecutive years, with $78.1 million as the latest value for Q2 2025.

  • Quarterly Shares Outstanding rose 383.3% to $78.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $78.1 million through Jun 2025, up 383.3% year-over-year, with the annual reading at $16.4 million for FY2024, 2.65% up from the prior year.
  • Shares Outstanding hit $78.7 million in Q3 2025 for Hinge Health, up from $78.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $78.7 million in Q3 2025 to a low of $16.0 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $36.9 million across 3 years, with a median of $16.3 million in 2024.
  • Biggest five-year swings in Shares Outstanding: grew 2.65% in 2024 and later soared 383.3% in 2025.
  • Year by year, Shares Outstanding stood at $16.0 million in 2023, then rose by 2.65% to $16.4 million in 2024, then surged by 376.96% to $78.1 million in 2025.
  • Business Quant data shows Shares Outstanding for HNGE at $78.1 million in Q2 2025, $16.4 million in Q4 2024, and $16.3 million in Q3 2024.